Zobrazeno 1 - 6
of 6
pro vyhledávání: '"drug therapy [Cognition Disorders]"'
Autor:
Gianluigi Forloni, Federica Fusco, Alessio Colombo, Emanuele Nardo, Ottavia Bernocchi, Gloria Biella, Diego Albani, Stefan F. Lichtenthaler
Publikováno v:
Journal of Alzheimer's disease 53(3), 1193-1207 (2016). doi:10.3233/JAD-151135
The neuropathological hallmarks of Alzheimer's disease (AD) are extracellular plaques built up by the accumulation of the amyloid-β protein precursor (AβPP)-derived peptide β (Aβ), and intracellular tangles of hyperphosphorylated tau protein. Sir
Publikováno v:
Journal of Parkinson's Disease 8(3), 409-420 (2018). doi:10.3233/JPD-181380
Background: Non-motor symptoms (NMS) are common in late stage Parkinson's disease (PD), as the frequency and severity of most of these symptoms increase with advancing disease. Objective: To assess effect of dopaminergic therapy on NMS in late stage
Autor:
Tursonjan Tokay, Timo Kirschstein, Mischa Uebachs, Katharina Klatte, Maria Kober, David M. Otte, Andreas Zimmer, Leonie Pothmann, Heinz Beck, Lorenz Müller
Publikováno v:
The journal of neuroscience 33(32), 13066-13080 (2013). doi:10.1523/JNEUROSCI.5423-12.2013
The modulation of synaptic plasticity by NMDA receptor (NMDAR)-mediated processes is essential for many forms of learning and memory. Activation of NMDARs by glutamate requires the binding of a coagonist to a regulatory site of the receptor. In many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617da5f98206b4f6836a014b943fbeb1
https://pub.dzne.de/record/137012
https://pub.dzne.de/record/137012
Autor:
Susanne Schnell, Devon Ryan, Katharina Paesler, Markus Heinen, Moritz M. Hettich, Dan Ehninger
Publikováno v:
Neural Plasticity
Neural Plasticity, Vol 2012 (2012)
Neural plasticity 2012, 1-10 (2012). doi:10.1155/2012/467251
Neural Plasticity, Vol 2012 (2012)
Neural plasticity 2012, 1-10 (2012). doi:10.1155/2012/467251
Down syndrome is caused by triplication of chromosome 21 and is associated with neurocognitive phenotypes ranging from severe intellectual disability to various patterns of more selective neuropsychological deficits, including memory impairments. In
Autor:
Leonhard Lennertz, Michael Wagner, Heinz Häfner, Anna Schuhmacher, Dan Rujescu, Rainald Mössner, Boris B. Quednow, Wolfgang Maier, Petra Franke, Marcella Rietschel, Wolfgang Wölwer, Tim Becker, Jens Benninghoff, Wolfgang Gaebel
Publikováno v:
Journal of psychiatric research 46(8), 1073-1080 (2012). doi:10.1016/j.jpsychires.2012.04.021
Journal of Psychiatric Research; Vol 46
Journal of psychiatric research
Journal of Psychiatric Research; Vol 46
Journal of psychiatric research
Serotonergic transmission is considered relevant in the pathophysiology and the treatment of schizophrenia. Tryptophan hydroxylase (TPH) is the rate limiting enzyme in the biosynthesis of serotonin. While the TPH1 gene has been found to be associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794ae0b703ad9890e0efcc11a72840ea
https://pub.dzne.de/record/136586
https://pub.dzne.de/record/136586
Autor:
Hochgräfe, Katja, Sydow, Astrid, Mandelkow, Eva-Maria, Matenia, Dorthe, Cadinu, Daniela, Könen, Stefanie, Petrova, Olga, Pickhardt, Marcus, Goll, Petra, Morellini, Fabio, Mandelkow, Eckhard
Publikováno v:
Acta Neuropathologica Communications
Acta Neuropathologica Communications 3(1), 25 (2015). doi:10.1186/s40478-015-0204-4
Acta Neuropathologica Communications 3(1), 25 (2015). doi:10.1186/s40478-015-0204-4
Introduction Neurofibrillary tangles (NFT) composed of Tau are hallmarks of neurodegeneration in Alzheimer disease. Transgenic mice expressing full-length pro-aggregant human Tau (2N4R Tau-ΔK280, termed TauΔK) or its repeat domain (TauRD-ΔK280, Ta